Mass General Brigham, Inc
CIK: 0001678378Latest portfolio: $809.8M · Q4 2025
Holdings
7
Total Value
$809.8M
New Positions
7
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACWIISHARES TR | 4,613,955 | $652.8M | 80.62% | |
| 2 | KRMNKARMAN HLDGS INC | 1,562,054 | $114.3M | 14.11% | |
| 3 | RVMDREVOLUTION MEDICINES INC | 344,091 | $27.4M | 3.38% | |
| 4 | MAZEMAZE THERAPEUTICS INC | 239,994 | $9.9M | 1.23% | |
| 5 | TNGXTANGO THERAPEUTICS INC | 354,192 | $3.1M | 0.39% | |
| 6 | MDLNMEDLINE INC | 26,294 | $1.1M | 0.14% | |
| 7 | RBRKRUBRIK INC | 14,000 | $1.1M | 0.13% |
Sector Breakdown
Healthcare0.0% ($27406994.2T)
Financial Services0.0% ($652.8M)
Industrials0.0% ($114.3M)
Technology0.0% ($1.1M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Jan 27, 2026 | $809.8M | 7 |
Fund Information
Mass General Brigham, Inc is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $809.8M across 7 holdings. The largest position is ISHARES TR (ACWI), representing 80.6% of the portfolio. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.